Viracta and Salubris Announce Equity Financing and Partnership to Bring Novel Treatment for Viral-Associated Cancers to China Life Science
Cronos Group Confirms Discussions Regarding Potential Investment by Altria Group Cannabis, Life Science
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®) Life Science
Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors Life Science
YITU releases the world’s first AI-based cancer screening solutions at the 2018 RSNA Annual Meeting Life Science
Body and Mind Enters Agreement to Acquire Iconic Dispensary Chain in California Cannabis, Life Science
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs Life Science
Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors Life Science